Columbus VP invests in early-stage biotechnology and pharmaceutical companies.
The 4th Columbus Life Sciences Fund continues its proven strategy of identifying and expanding high-potential early-stage biotechnology and pharmaceutical companies. The managers, with deep and unique and unique commercial and scientific expertise, have consistently executed their strategy, fostering life-changing medical solutions.